Literature DB >> 11917942

Identification of a gene frequently mutated in prostate tumors.

D J Reding1, K Q Zhang, S A Salzman, J V Thomalla, R E Riepe, B K Suarez, W J Catalona, J K Burmester.   

Abstract

Although prostate cancer is the second leading cause of cancer death for men in the United States, the genetics of tumor development are poorly understood. Several expressed sequence tagged genes (ESTs) that are expressed predominantly in the prostate have recently been identified, although their role in the development and maintenance of the prostate is unknown. Here, we demonstrate that the gene identified as UNIGENE cluster Hs. 104215, which codes for a message found predominantly in the prostate, may be important in tumor development. We name this gene PCan1 for Prostate Cancer gene 1. Northern blot experiments were performed using RNA isolated from tumor-derived cell lines and human prostate to determine the expression pattern of the gene. DNA sequencing was used to identify mutations that occurred in tumor tissue. By Northern blot analysis, this gene product was not detectable in LNCaP, DU 145, or PC-3 prostate cancer cell lines, although it was readily observed in RNA isolated from total prostate and from dissected central and peripheral regions of prostate. Sequence analysis of genomic DNA from LNCaP, DU 145, or PC-3 cells demonstrated a G/A polymorphism at position 193. Analysis of matched tumor-derived DNA and blood-derived DNA samples from 11 of 13 patients who had undergone a radical prostatectomy and who were homozygous for A in blood-derived DNA demonstrated mutation of position 193 in matched tumor samples resulting in G/A polymorphism. Sixteen additional patient samples were G/A polymorphic in both blood-derived DNA and tumor-derived DNA and two samples were GG in both blood-derived and tumor-derived DNA. Our results suggest that this gene may be a hot spot for mutation in prostate cancer, especially because our radiation hybrid mapping located this gene within a region identified in linkage mapping studies of affected families with prostate cancer. Loss of heterozygosity in prostate tumors has also been reported at the location of PCan1. Further studies to determine the functional role of this candidate tumor suppressor gene are warranted.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11917942     DOI: 10.1385/MO:18:3:179

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  27 in total

1.  A genome screen of multiplex sibships with prostate cancer.

Authors:  B K Suarez; J Lin; J K Burmester; K W Broman; J L Weber; T K Banerjee; K A Goddard; J S Witte; R C Elston; W J Catalona
Journal:  Am J Hum Genet       Date:  2000-03       Impact factor: 11.025

2.  Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43.

Authors:  P Berthon; A Valeri; A Cohen-Akenine; E Drelon; T Paiss; G Wöhr; A Latil; P Millasseau; I Mellah; N Cohen; H Blanché; C Bellané-Chantelot; F Demenais; P Teillac; A Le Duc; R de Petriconi; R Hautmann; I Chumakov; L Bachner; N J Maitland; R Lidereau; W Vogel; G Fournier; P Mangin; O Cussenot
Journal:  Am J Hum Genet       Date:  1998-06       Impact factor: 11.025

Review 3.  Epidemiology of prostate cancer: molecular and environmental clues.

Authors:  K J Pienta; J A Goodson; P S Esper
Journal:  Urology       Date:  1996-11       Impact factor: 2.649

4.  A catalogue of splice junction sequences.

Authors:  S M Mount
Journal:  Nucleic Acids Res       Date:  1982-01-22       Impact factor: 16.971

5.  PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer.

Authors:  V Srikantan; Z Zou; G Petrovics; L Xu; M Augustus; L Davis; J R Livezey; T Connell; I A Sesterhenn; K Yoshino; G S Buzard; F K Mostofi; D G McLeod; J W Moul; S Srivastava
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

6.  Association of HPC2/ELAC2 genotypes and prostate cancer.

Authors:  T R Rebbeck; A H Walker; C Zeigler-Johnson; S Weisburg; A M Martin; K L Nathanson; A J Wein; S B Malkowicz
Journal:  Am J Hum Genet       Date:  2000-09-12       Impact factor: 11.025

7.  DD3: a new prostate-specific gene, highly overexpressed in prostate cancer.

Authors:  M J Bussemakers; A van Bokhoven; G W Verhaegh; F P Smit; H F Karthaus; J A Schalken; F M Debruyne; N Ru; W B Isaacs
Journal:  Cancer Res       Date:  1999-12-01       Impact factor: 12.701

8.  PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer.

Authors:  J Li; C Yen; D Liaw; K Podsypanina; S Bose; S I Wang; J Puc; C Miliaresis; L Rodgers; R McCombie; S H Bigner; B C Giovanella; M Ittmann; B Tycko; H Hibshoosh; M H Wigler; R Parsons
Journal:  Science       Date:  1997-03-28       Impact factor: 47.728

9.  Assessment of binding of 2,4,4-trimethyl-2-pentanol to low-molecular-weight proteins isolated from kidneys of male rats and humans.

Authors:  S J Borghoff; W H Lagarde
Journal:  Toxicol Appl Pharmacol       Date:  1993-04       Impact factor: 4.219

10.  Chromosomal changes during development and progression of prostate adenocarcinomas.

Authors:  H Zitzelsberger; D Engert; A Walch; U Kulka; M Aubele; H Höfler; M Bauchinger; M Werner
Journal:  Br J Cancer       Date:  2001-01       Impact factor: 7.640

View more
  5 in total

1.  Expression and initial promoter characterization of PCAN1 in retinal tissue and prostate cell lines.

Authors:  D Cross; D J Reding; S A Salzman; K Q Zhang; W J Catalona; J Burke; J K Burmester
Journal:  Med Oncol       Date:  2004       Impact factor: 3.064

2.  Functional characterization of the GDEP promoter and three enhancer elements in retinoblastoma and prostate cell lines.

Authors:  D S Cross; J K Burmester
Journal:  Med Oncol       Date:  2007-06-27       Impact factor: 3.064

3.  Characterization of two functional NKX3.1 binding sites upstream of the PCAN1 gene that are involved in the positive regulation of PCAN1 gene transcription.

Authors:  Wenwen Liu; Pengju Zhang; Weiwen Chen; Chunxiao Yu; Fuai Cui; Feng Kong; Jianye Zhang; Anli Jiang
Journal:  BMC Mol Biol       Date:  2008-05-04       Impact factor: 2.946

4.  Molecular cloning and analysis of the human PCAN1 (GDEP) promoter.

Authors:  Wenwen Liu; Weiwen Chen; Pengju Zhang; Chunxiao Yu; Feng Kong; Jingti Deng; Jianye Zhang; Anli Jiang
Journal:  Cell Mol Biol Lett       Date:  2007-04-28       Impact factor: 5.787

5.  The long noncoding RNA landscape of neuroendocrine prostate cancer and its clinical implications.

Authors:  Varune Rohan Ramnarine; Mohammed Alshalalfa; Fan Mo; Noushin Nabavi; Nicholas Erho; Mandeep Takhar; Robert Shukin; Sonal Brahmbhatt; Alexander Gawronski; Maxim Kobelev; Mannan Nouri; Dong Lin; Harrison Tsai; Tamara L Lotan; R Jefferey Karnes; Mark A Rubin; Amina Zoubeidi; Martin E Gleave; Cenk Sahinalp; Alexander W Wyatt; Stanislav V Volik; Himisha Beltran; Elai Davicioni; Yuzhuo Wang; Colin C Collins
Journal:  Gigascience       Date:  2018-06-01       Impact factor: 6.524

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.